Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.Wei‐Fan Hsu, Cheng‐Yuan Peng, Cheng‐Kuo Chen et al.|PubMed|2021Cited by 19